Cited by 44Cardiac Health and Mental HealthPhysical Activity and HealthTreatment of Major Depression

Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial

Open access
Sherwood, Andrew, Blumenthal, James A., Smith, Patrick J., Watkins, Lana L., Hoffman, Benson M., Hinderliter, Alan L.·2016·Psychosomatic Medicine

Abstract

Objective: To assess the effects of supervised and home-based aerobic exercise training, and antidepressant pharmacotherapy (sertraline) on coronary heart disease (CHD) risk factors in a sample of participants with major depressive disorder (MDD). Methods: The Standard Medical Intervention versus Long-term Exercise (SMILE)-II study randomized 202 adults (153 women, 49 men) diagnosed as having MDD to one of four interventions, each of 4-month duration: supervised exercise, home-based exercise, antidepressant medication (sertraline, 50–200 mg daily), or placebo pill. Patients underwent a structured clinical interview for depression and completed the Hamilton Depression Rating Scale. CHD risk factors included brachial artery flow-mediated dilation, carotid intima-media thickness, serum lipids, and 10-year atherosclerotic cardiovascular disease (ASCVD) risk. Results: Compared with placebo, active treatment of depression (supervised exercise, home-based exercise, sertraline therapy) was associated with an improvement in CHD risk factors (improved flow-mediated dilation [p= .032], reduced progression of intima-media thickness [p= .037], and a reduction in 10-year ASCVD [p= .049]). The active treatments did not differ from each other in their effects on the CHD risk outcomes. Conclusions: Both exercise and antidepressant medication improved CHD risk factors and lowered ASCVD risk in patients with MDD. Because MDD is associated with increased risk for CHD events, treatment of depression with exercise or sertraline may reduce the risk of developing CHD in patients with MDD. Trial Registration:Clinical Trials Government Identifier: NCT-00331305.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/psy.0000000000000301

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sherwood, A., Blumenthal, J. A., Smith, P. J., Watkins, L. L., Hoffman, B. M., & Hinderliter, A. L.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
Sherwood, Andrew
Venue
Psychosomatic Medicine
Published
2016-06
Volume
78
Issue
5
Pages
602-609
ISSN
  • 0033-3174 (ISSN-L)
  • 1534-7796
OpenAlex
W2342034212
Cited by
44
References
41
Citations by year
2026: 5 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 3
FWCI
2.75
Type
journal article
Language
en
Open access
Locations
  • Psychosomatic Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL093374, R01HL101383)
  • National Institute of Mental Health (R01MH049679)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
major depressive disorder, coronary heart disease risk, aerobic exercise training, home-based exercise, supervised exercise, sertraline, antidepressant treatment, flow-mediated dilation, carotid intima-media thickness, serum lipids, atherosclerotic cardiovascular disease risk, cardiovascular risk factors
MeSH terms
Adult, Combined Modality Therapy, Coronary Disease, Major Depressive Disorder, Exercise Therapy, Female, Humans, Male, Middle Aged, Risk, Outcome Assessment, Health Care, Selective Serotonin Reuptake Inhibitors, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review